TiterTACS In Situ Detection Kit - Colorimetric

Catalog # Availability Size / Price Qty
4822-96-K
TiterTACS In Situ Detection Kit_4822-96-K
1 Image
Product Details
Citations (37)
FAQs
Supplemental Products
Reviews (1)

TiterTACS In Situ Detection Kit - Colorimetric Summary

TiterTacs in situ (Catalog # 4822-096-K)
Detection of Apoptosis in Staurosporin-treaded ML-1 Cells
Human ML-1 myeloblastic leukemia cells were treated with 1 µM staurosporine and then harvested, fixed, and labeled according to the protocol in the TiterTACS Kit (Catalog # 4822-96-K) prior to colorimetric analy

TiterTACS® in situ

A complete kit supplied with TACS-Sapphire optimized for colorimetric detection in 96-well plates, and all the reagents necessary for generating positive controls.

Label: Biotin/Streptavidin-HRP/TACS Sapphire™
Testing Format: Plate Reader
Sample Type: Suspended or monolayer cells
Size: 96 Tests


TiterTACS and TACS Sapphire are trademarks of Trevigen, Inc.

Specifications

Shipping Conditions
The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Storage
The product  requires storage at both -20 to -70 °C and 2 - 8 °C.  Consult the product insert for specific storage temperatures. Do not use past expiration date.

Product Datasheets

You must select a language.

x

Scientific Data

Detection of Apoptosis in Staurosporine-treated ML-1 Cells. Human ML-1 myeloblastic leukemia cells were treated with 1 µM staurosporine and then harvested, fixed, and labeled according to the protocol in the TiterTACS In Situ Detection Kit (Catalog # 4822-96-K) prior to colorimetric analysis.

Citations for TiterTACS In Situ Detection Kit - Colorimetric

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

37 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Selective Effects of Cold Atmospheric Plasma on Bone Sarcoma Cells and Human Osteoblasts
    Authors: A Nitsch, KF Sieb, S Qarqash, J Schoon, A Ekkernkamp, GI Wassilew, M Niethard, L Haralambie
    Biomedicines, 2023-02-17;11(2):.  2023-02-17
  2. Involvement of microRNA miR-125b in the control of porcine ovarian cell functions
    Authors: Z Fabová, B Loncová, M Bauer, AV Sirotkin
    General and comparative endocrinology, 2023-01-17;334(0):114215.  2023-01-17
  3. Pleiotropic Devitalization of Renal Cancer Cells by Non-Invasive Physical Plasma: Characterization of Molecular and Cellular Efficacy
    Authors: A Nitsch, C Sander, B Eggers, M Weiss, E Egger, FJ Kramer, HHH Erb, A Mustea, MB Stope
    Cancers, 2023-01-12;15(2):.  2023-01-12
  4. Efficacy of Clinically Used PARP Inhibitors in a Murine Model of Acute Lung Injury
    Authors: V Martins, SS Santos, LOCP Rodrigues, R Salomao, L Liaudet, C Szabo
    Cells, 2022-11-26;11(23):.  2022-11-26
  5. GSK3beta Inhibition Is the Molecular Pivot That Underlies the Mir-210-Induced Attenuation of Intrinsic Apoptosis Cascade during Hypoxia
    Authors: G Marwarha, Ø Røsand, KH Slagsvold, MA Høydal
    International Journal of Molecular Sciences, 2022-08-19;23(16):.  2022-08-19
  6. New Approach against Chondrosoma Cells-Cold Plasma Treatment Inhibits Cell Motility and Metabolism, and Leads to Apoptosis
    Authors: A Nitsch, S Strakeljah, JM Jacoby, KF Sieb, A Mustea, S Bekeschus, A Ekkernkamp, MB Stope, L Haralambie
    Biomedicines, 2022-03-17;10(3):.  2022-03-17
  7. Pharmacological perturbation of CXCL1 signaling alleviates neuropathogenesis in a model of HEVA71 infection
    Authors: S Gunaseelan, MZ Ariffin, S Khanna, MH Ooi, D Perera, JJH Chu, JJE Chua
    Nature Communications, 2022-02-16;13(1):890.  2022-02-16
  8. ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma
    Authors: GL Gravina, A Colapietro, A Mancini, A Rossetti, S Martellucc, L Ventura, M Di Franco, F Marampon, V Mattei, LA Biordi, M Otterlei, C Festuccia
    Cancers, 2022-01-07;14(2):.  2022-01-07
  9. miR-210 Regulates Apoptotic Cell Death during Cellular Hypoxia and Reoxygenation in a Diametrically Opposite Manner
    Authors: G Marwarha, Ø Røsand, N Scrimgeour, KH Slagsvold, MA Høydal
    Biomedicines, 2021-12-25;10(1):.  2021-12-25
  10. Cytotoxicity and pro-apoptosis activity of synthetic 1,3-thiazole incorporated phthalimide derivatives on cancer cells
    Authors: O Tavallaei, M Heidarian, M Marzbany, A Aliabadi
    Iranian journal of basic medical sciences, 2021-05-01;24(5):604-614.  2021-05-01
  11. Piwi-Interacting RNA1037 Enhances Chemoresistance and Motility in Human Oral Squamous Cell Carcinoma Cells
    Authors: G Li, X Wang, C Li, S Hu, Z Niu, Q Sun, M Sun
    Onco Targets Ther, 2019-12-04;12(0):10615-10627.  2019-12-04
  12. Cold atmospheric plasma inhibits the growth of osteosarcoma cells by inducing apoptosis, independent of the device used
    Authors: L Haralambie, L Wien, N Gelbrich, J Lange, S Bakir, A Kramer, M Burchardt, A Ekkernkamp, D Gümbel, MB Stope
    Oncol Lett, 2019-11-19;19(1):283-290.  2019-11-19
  13. Induced Tamoxifen Resistance is Mediated by Increased Methylation of E-Cadherin in Estrogen Receptor-Expressing Breast Cancer Cells
    Authors: Q Wang, M Gun, XY Hong
    Sci Rep, 2019-10-02;9(1):14140.  2019-10-02
  14. High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases
    Authors: MJ Strowitzki, P Radhakrish, S Pavicevic, J Scheer, G Kimmer, AS Ritter, C Tuffs, C Volz, F Vondran, JM Harnoss, J Klose, T Schmidt, M Schneider
    Br. J. Cancer, 2019-02-27;0(0):.  2019-02-27
  15. Metformin Inhibit Lung Cancer Cell Growth and Invasion in Vitro as Well as Tumor Formation in Vivo Partially by Activating PP2A
    Authors: X Zhou, S Liu, X Lin, L Xu, X Mao, J Liu, Z Zhang, W Jiang, H Zhou
    Med. Sci. Monit., 2019-01-29;25(0):836-846.  2019-01-29
  16. Beta Adrenergic Receptors Stimulation Attenuates Phosphorylation of NF-?B and I?B? in Hyperglycemic Endothelial Cells
    Authors: SZ Safi, H Shah, R Qvist, P Bindal, M Mansor, GOS Yan, ISB Ismail
    Cell. Physiol. Biochem., 2018-11-28;51(3):1429-1436.  2018-11-28
  17. Combined Effect of Anticancer Agents and Cytochrome C Decorated Hybrid Nanoparticles for Liver Cancer Therapy
    Authors: W Al-Shakarc, A Alsuraifi, M Abed, M Abdullah, A Richardson, A Curtis, C Hoskins
    Pharmaceutics, 2018-04-12;10(2):.  2018-04-12
  18. Peptidoglycan-associated lipoprotein of Aggregatibacter actinomycetemcomitans induces apoptosis and production of proinflammatory cytokines via TLR2 in murine macrophages RAW 264.7 in vitro
    Authors: R Ihalin, K Eneslätt, S Asikainen
    J Oral Microbiol, 2018-03-06;10(1):1442079.  2018-03-06
  19. Cystic fibrosis epithelial cells are primed for apoptosis as a result of increased Fas (CD95)
    Authors: Q Chen, SPS Pandi, L Kerrigan, NG McElvaney, CM Greene, JS Elborn, CC Taggart, S Weldon
    J. Cyst. Fibros., 2018-03-02;0(0):.  2018-03-02
  20. A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome
    Authors: JE Kanter, F Kramer, S Barnhart, JM Duggan, M Shimizu-Al, V Kothari, A Chait, SD Bouman, JA Hamerman, BF Hansen, GS Olsen, KE Bornfeldt
    Diabetes, 2018-02-26;0(0):.  2018-02-26
  21. Anti-ganglioside GD2 monoclonal antibody synergizes with cisplatin to induce endoplasmic reticulum-associated apoptosis in osteosarcoma cells
    Authors: W Zhu, X Mao, W Wang, Y Chen, D Li, H Li, P Dou
    Pharmazie, 2018-02-01;73(2):80-86.  2018-02-01
  22. Activated protein C suppresses osteoclast differentiation via endothelial protein C receptor, protease-activated receptor-1, sphingosine 1-phosphate receptor, and apolipoprotein E receptor 2
    Authors: K Yoshida, N Akita, T Okamoto, K Asanuma, A Uchida, A Sudo, M Shimaoka, K Suzuki, T Hayashi
    Thromb. Res., 2018-01-03;163(0):30-40.  2018-01-03
  23. The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival
    Authors: P Vange, T Bruland, B Doseth, R Fossmark, MML Sousa, V Beisvag, Ø Sørdal, G Qvigstad, HL Waldum, AK Sandvik, I Bakke
    PLoS ONE, 2017-09-13;12(9):e0184514.  2017-09-13
  24. Hemin Causes Lung Microvascular Endothelial Barrier Dysfunction by Necroptotic Cell Death.
    Authors: Singla S, Sysol J, Dille B, Jones N, Chen J, Machado R
    Am J Respir Cell Mol Biol, 2017-09-01;57(3):307-314.  2017-09-01
  25. Detection and Quantification of Nuclear Morphology Changes in Apoptotic Cells by Fluorescence Microscopy and Subsequent Analysis of Visualized Fluorescent Signals.
    Authors: Mandelkow R, Gumbel D, Ahrend H, Kaul A, Zimmermann U, Burchardt M, Stope M
    Anticancer Res, 2017-05-01;37(5):2239-2244.  2017-05-01
  26. Long noncoding RNA MALAT1 inhibits apoptosis induced by oxygen-glucose deprivation and reoxygenation in human brain microvascular endothelial cells
    Authors: JW Xin, YG Jiang
    Exp Ther Med, 2017-02-02;13(4):1225-1234.  2017-02-02
  27. Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor olaparib by a dominant negative effect.
    Authors: Vaclova T, Woods N, Megias D, Gomez-Lopez S, Setien F, Garcia Bueno J, Macias J, Barroso A, Urioste M, Esteller M, Monteiro A, Benitez J, Osorio A
    Hum Mol Genet, 2016-12-15;25(24):5287-5299.  2016-12-15
  28. Desensitization of idiopathic pulmonary fibrosis fibroblasts to Alternaria alternata extract-mediated necrotic cell death.
    Authors: Im J, Kim K, Yhee J, O'Grady S, Nho R
    Physiol Rep, 2016-11-15;4(21):.  2016-11-15
  29. ADAM12: a genetic modifier of preclinical peripheral arterial disease.
    Authors: Dokun A, Chen L, Okutsu M, Farber C, Hazarika S, Jones W, Craig D, Marchuk D, Lye R, Shah S, Annex B
    Am J Physiol Heart Circ Physiol, 2015-07-10;309(5):H790-803.  2015-07-10
  30. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
    Authors: Zhou Y, Zhang L, Pan H, Wang B, Yan F, Fang X, Munnee K, Tang Z
    PLoS ONE, 2015-04-27;10(4):e0123208.  2015-04-27
  31. Visceral adipose tissue-derived serine proteinase inhibitor inhibits apoptosis of endothelial cells as a ligand for the cell-surface GRP78/voltage-dependent anion channel complex.
    Authors: Nakatsuka A, Wada J, Iseda I, Teshigawara S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Hida K, Eguchi J, Ogawa D, Matsuki Y, Hiramatsu R, Yagita H, Kakuta S, Iwakura Y, Makino H
    Circ Res, 2013-01-10;112(5):771-80.  2013-01-10
  32. OGDHL is a modifier of AKT-dependent signaling and NF-kappaB function.
    Authors: Sen T, Sen N, Noordhuis M, Ravi R, Wu T, Ha P, Sidransky D, Hoque M
    PLoS ONE, 2012-11-12;7(11):e48770.  2012-11-12
  33. Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter.
    Authors: McCluskey A, Mairs R, Tesson M, Pimlott S, Babich J, Gaze M, Champion S, Boyd M
    J Nucl Med, 2012-06-11;53(7):1146-54.  2012-06-11
  34. Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease.
    Authors: Byun K, Bayarsaikhan E, Kim D, Kim CY, Mook-Jung I, Paek SH, Kim SU, Yamamoto T, Won MH, Song BJ, Park YM, Lee B
    PLoS ONE, 2012-05-25;7(5):e37917.  2012-05-25
  35. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1.
    Authors: Kanter J, Kramer F, Barnhart S, Averill M, Vivekanandan-Giri A, Vickery T, Li L, Becker L, Yuan W, Chait A, Braun K, Potter-Perigo S, Sanda S, Wight T, Pennathur S, Serhan C, Heinecke J, Coleman R, Bornfeldt K
    Proc Natl Acad Sci U S A, 2012-01-17;109(12):E715-24.  2012-01-17
  36. The P2Y6 Receptor Stimulates Bone Resorption by Osteoclasts.
    Authors: Orriss IR, Wang N, Burnstock G
    Endocrinology, 2011-08-09;152(10):3706-16.  2011-08-09
  37. Rubus coreanus Miq. extract promotes osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells.
    Authors: Lee KH, Choi EM
    Am. J. Chin. Med., 2006-01-01;34(4):643-54.  2006-01-01

FAQs

No product specific FAQs exist for this product, however you may

View all Activity Assay FAQs
Loading...

Reviews for TiterTACS In Situ Detection Kit - Colorimetric

Average Rating: 3 (Based on 1 Review)

5 Star
0%
4 Star
0%
3 Star
100%
2 Star
0%
1 Star
0%

Have you used TiterTACS In Situ Detection Kit - Colorimetric?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


TiterTACS In Situ Detection Kit - Colorimetric
By Marzena Knyssok-Sypniewski on 09/12/2016